Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 266

1.

Quantitative miR analysis in chronic lymphocytic leukaemia/small lymphocytic lymphoma - proliferation centres are characterized by high miR-92a and miR-155 and low miR-150 expression.

Szurián K, Csala I, Piurkó V, Deák L, Matolcsy A, Reiniger L.

Leuk Res. 2017 Jul;58:39-42. doi: 10.1016/j.leukres.2017.04.002. Epub 2017 Apr 4.

PMID:
28407516
2.

The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia.

Guinn D, Lehman A, Fabian C, Yu L, Maddocks K, Andritsos LA, Jones JA, Flynn JM, Jaglowski SM, Woyach JA, Byrd JC, Johnson AJ.

Cancer Med. 2017 Apr;6(4):778-787. doi: 10.1002/cam4.996. Epub 2017 Mar 15.

3.

miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study.

Gagez AL, Duroux-Richard I, Leprêtre S, Orsini-Piocelle F, Letestu R, De Guibert S, Tuaillon E, Leblond V, Khalifa O, Gouilleux-Gruart V, Banos A, Tournilhac O, Dupuis J, Jorgensen C, Cartron G, Apparailly F.

Haematologica. 2017 Apr;102(4):746-754. doi: 10.3324/haematol.2016.153189. Epub 2017 Jan 25.

4.

Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.

Cutrona G, Matis S, Colombo M, Massucco C, Baio G, Valdora F, Emionite L, Fabris S, Recchia AG, Gentile M, Neumaier CE, Reverberi D, Massara R, Boccardo S, Basso L, Salvi S, Rosa F, Cilli M, Zupo S, Truini M, Tassone P, Calabrese M, Negrini M, Neri A, Morabito F, Fais F, Ferrarini M.

Leukemia. 2017 Sep;31(9):1894-1904. doi: 10.1038/leu.2016.394. Epub 2017 Jan 5.

PMID:
28053325
5.

Role of microRNAs in regulation of the TNF/TNFR gene superfamily in chronic lymphocytic leukemia.

Srivastava S, Tsongalis GJ, Kaur P.

Clin Biochem. 2016 Nov;49(16-17):1307-1310. doi: 10.1016/j.clinbiochem.2016.08.010. Epub 2016 Aug 17.

PMID:
27544753
6.

Pitfalls of analysis of circulating miRNA: role of hematocrit.

Mayr B, Mueller EE, Schäfer C, Breitenbach-Koller H, Schönfelder M, Niebauer J.

Clin Chem Lab Med. 2017 May 1;55(5):622-625. doi: 10.1515/cclm-2016-0323. No abstract available.

PMID:
27768582
7.

MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.

Caivano A, La Rocca F, Simeon V, Girasole M, Dinarelli S, Laurenzana I, De Stradis A, De Luca L, Trino S, Traficante A, D'Arena G, Mansueto G, Villani O, Pietrantuono G, Laurenti L, Del Vecchio L, Musto P.

Cell Oncol (Dordr). 2017 Feb;40(1):97-103. doi: 10.1007/s13402-016-0300-x. Epub 2016 Oct 19.

PMID:
27761889
8.

Targeting BTK through microRNA in chronic lymphocytic leukemia.

Bottoni A, Rizzotto L, Lai TH, Liu C, Smith LL, Mantel R, Reiff S, El-Gamal D, Larkin K, Johnson AJ, Lapalombella R, Lehman A, Plunkett W, Byrd JC, Blachly JS, Woyach JA, Sampath D.

Blood. 2016 Dec 29;128(26):3101-3112. doi: 10.1182/blood-2016-07-727750. Epub 2016 Oct 17.

PMID:
27756747
9.

Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle.

Filip AA, Grenda A, Popek S, Koczkodaj D, Michalak-Wojnowska M, Budzyński M, Wąsik-Szczepanek E, Zmorzyński S, Karczmarczyk A, Giannopoulos K.

Ann Hematol. 2017 Jan;96(1):33-50. doi: 10.1007/s00277-016-2840-6. Epub 2016 Oct 12.

10.

MicroRNAs in Chronic Lymphocytic Leukemia: An Old Disease with New Genetic Insights.

Ciccone M, Calin GA.

Microrna. 2016;5(2):106-112. Review.

PMID:
27568792
11.

Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia.

Underbayev C, Kasar S, Ruezinsky W, Degheidy H, Schneider JS, Marti G, Bauer SR, Fraidenraich D, Lightfoote MM, Parashar V, Raveche E, Batish M.

Oncotarget. 2016 Sep 20;7(38):60986-60999. doi: 10.18632/oncotarget.11290.

12.

Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia.

Saleh LM, Wang W, Herman SE, Saba NS, Anastas V, Barber E, Corrigan-Cummins M, Farooqui M, Sun C, Sarasua SM, Zhao Z, Abousamra NK, Elbaz O, Abdelghaffar HA, Wiestner A, Calvo KR.

Leukemia. 2017 Feb;31(2):340-349. doi: 10.1038/leu.2016.181. Epub 2016 Jun 24.

PMID:
27431016
13.

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome.

Rozovski U, Hazan-Halevy I, Calin G, Harris D, Li P, Liu Z, Keating MJ, Estrov Z.

J Vis Exp. 2016 Jun 15;(112). doi: 10.3791/53300.

PMID:
27341356
14.

Dissecting chronic lymphocytic leukemia with 13q- using microRNA expression profile: Editorial for the paper "MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion".

Musto P, Negrini M, De Luca L, Cuneo A.

Leuk Res. 2016 Aug;47:114-5. doi: 10.1016/j.leukres.2016.05.024. Epub 2016 May 27. No abstract available.

PMID:
27304710
15.

miR-155 as a Biomarker in B-Cell Malignancies.

Due H, Svendsen P, Bødker JS, Schmitz A, Bøgsted M, Johnsen HE, El-Galaly TC, Roug AS, Dybkær K.

Biomed Res Int. 2016;2016:9513037. doi: 10.1155/2016/9513037. Epub 2016 May 16. Review.

16.

Novel mechanisms of regulation of miRNAs in CLL.

Balatti V, Acunzo M, Pekarky Y, Croce CM.

Trends Cancer. 2016 Mar;2(3):134-143.

17.

Extracellular vesicles released by CD40/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cells.

Smallwood DT, Apollonio B, Willimott S, Lezina L, Alharthi A, Ambrose AR, De Rossi G, Ramsay AG, Wagner SD.

Blood. 2016 Jul 28;128(4):542-52. doi: 10.1182/blood-2015-11-682377. Epub 2016 Apr 26.

18.

MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion.

Hernández-Sánchez M, Rodríguez-Vicente AE, Hernández JÁ, Lumbreras E, Sarasquete ME, Martín AÁ, Benito R, Vicente-Gutiérrez C, Robledo C, Heras Nde L, Rodríguez JN, Alcoceba M, Coca AG, Aguilar C, González M, Hernández-Rivas JM.

Leuk Res. 2016 Jul;46:30-6. doi: 10.1016/j.leukres.2016.04.008. Epub 2016 Apr 12.

PMID:
27111859
19.

Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer.

Pekarsky Y, Balatti V, Palamarchuk A, Rizzotto L, Veneziano D, Nigita G, Rassenti LZ, Pass HI, Kipps TJ, Liu CG, Croce CM.

Proc Natl Acad Sci U S A. 2016 May 3;113(18):5071-6. doi: 10.1073/pnas.1604266113. Epub 2016 Apr 11.

20.

B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4.

Ntoufa S, Papakonstantinou N, Apollonio B, Gounari M, Galigalidou C, Fonte E, Anagnostopoulos A, Belessi C, Muzio M, Ghia P, Stamatopoulos K.

J Immunol. 2016 May 15;196(10):4410-7. doi: 10.4049/jimmunol.1502297. Epub 2016 Apr 8.

Supplemental Content

Loading ...
Support Center